Trials / Not Yet Recruiting
Not Yet RecruitingNCT06070259
Insights Into Participating in Studies for Bone Cancer
Examining Patient Involvement Patterns and Trends in Participation in Bone Cancer Clinical Trials
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Power Life Sciences Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Clinical studies, with a distinct focus on bone cancer, play a crucial role in evaluating the safety and effectiveness of novel treatments for this disease. These trials serve as instrumental means to determine whether new medications surpass conventional therapies, providing substantial evidence for their broader adoption. The primary objective is to meticulously scrutinize trial completion rates and voluntary withdrawals within this specific patient group.
Conditions
Timeline
- Start date
- 2024-10-01
- Primary completion
- 2025-10-01
- Completion
- 2026-10-01
- First posted
- 2023-10-06
- Last updated
- 2023-10-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06070259. Inclusion in this directory is not an endorsement.